Furthermore, in adult high-grade gliomas, inactivating mutations in ATRX are mutually exclusive with activating mutations in the TERT promoter, providing genetic evidence that ATRX loss contributes to telomere maintenance via the ALT phenotype in this cancer subtype [15]. The gene discussed is ATRX; the disease is central nervous system cancer.